Fake medicines in Mexico, November 2025 – May 2026

Americans buying prescription medicines in Mexico are overlooking widespread drug counterfeiting in the country, and as AFPs popularize medical tourism to lower costs, what happens in Mexico’s drug supply chain is even more of a problem for Americans.

[...]

WHO Alert: Counterfeit Cancer Medicines Reported in Europe

A vial and box labeled Imfinzi

Information provided to WHO by AstraZeneca, the genuine manufacturer of IMFINZI, has confirmed that the products identified in this Alert are falsified. Laboratory analysis of samples of the falsified IMFINZI have been carried out by AstraZeneca. The analysis confirmed that the vials of the falsified product contained no active pharmaceutical ingredient.

[...]

Counterfeit Medicines Are a Problem in the European Union—A Problem that is Continuing to Grow

According to a report from Europol’s Intellectual Property Crime Threat Assessment 2019, “Counterfeit pharmaceuticals pose a growing threat to the EU, affecting a large number of Member States. A wide and increasingly diverse range of medicines is targeted by counterfeiters.”
The Europol ICP Threat Assessment reports that there has been an increase in seizures of counterfeit drugs used in the treatment of serious illnesses, as well as a growing number of counterfeit drug incidents affecting the legal drug supply chain. 

[...]

New Report Highlights Continued Illicit Online Prescription Drugs Sales In China

ASOP Global and LegitScript released a report analyzing the prevalence of illicit online sales of prescription drugs in China, a country where such sales are prohibited. Their analysis showed that about half of all Chinese online pharmaceuticals sellers are illicit, potentially exposing patients to counterfeit medicines, substandard medicines, financial fraud, and identity theft…

[...]

UK House of Commons: No Deal Brexit Exposes U.K. to Both Counterfeit Medication and Medication Shortages

In a report published by the House of Commons, experts in the field of prescription medication described a dire situation for medicine safety in the United Kingdom (UK) if a “no-deal” departure from the European Union (EU) happens. The report noted, “Witnesses told us that, without provisions with the EU to continue to exchange data, the UK would be shut out of critical EU data exchanges on pharmacovigilance, falsified medicines and clinical trials.”

[...]

Canadians Concerned About US Prescription Drug Importation Proposals

John Adams of the Best Medicines Coalition, a Canadian group that represents 28 different patient organizations, has described the Trump administration’s plan to import medication from Canada as a “clear and present danger” to the Canadian prescription drug system, according to AP.

[...]